CI vs LSTA · P/E 2.4, rev $274.90B vs rev $1.0M
Cigna Corp (CI) versus Lisata Therapeutics Inc. (LSTA) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Lisata Therapeutics Inc. (LSTA) is a biotechnology company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported LSTA revenue for 2024-12-31 was $1.0M. Net income was -$20.0M. LSTA currently screens at market cap $31.7M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. LSTA currently screens at market cap $31.7M.
Not investment advice. Open the CI and LSTA stock pages for the full models.
Not investment advice.